(NASDAQ: CODX) Co Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.74%.
Co Diagnostics's earnings in 2026 is -$46,895,936.On average, 4 Wall Street analysts forecast CODX's earnings for 2026 to be -$44,645,349, with the lowest CODX earnings forecast at -$47,660,612, and the highest CODX earnings forecast at -$40,851,953. On average, 3 Wall Street analysts forecast CODX's earnings for 2027 to be -$44,094,172, with the lowest CODX earnings forecast at -$42,364,988, and the highest CODX earnings forecast at -$45,391,059.
In 2028, CODX is forecast to generate -$25,354,149 in earnings, with the lowest earnings forecast at -$24,359,868 and the highest earnings forecast at -$26,099,859.